TransCode Therapeutics, Inc. (RNAZ) Earnings
|
Expand Research on RNAZ
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -55.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/14/25  |
Q225 | N/A | -$1.64 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/15/23 | Q123 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/30/23 | Q422 | N/A | -$0.38 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/14/22 | Q322 | N/A | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/15/22 | Q222 | -$0.97 | -$0.30 | -$0.67 | N/A | N/A | N/A |  | | Details |
